News in the Life Sciences Industry

PHILADELPHIA, Dec. 19, 2018 /PRNewswire/ -- New Rhein Healthcare Investors, an international private equity firm focused on healthcare therapeutics and medical devices, announced today the first closing of its inaugural pooled fund. The fund closed on $47.7 million of commitments with an additional... Read more ››

TOKYO, Dec. 18, 2018 /PRNewswire/ -- AGC (Headquarters: Tokyo; President: Takuya Shimamura) has announced a major enhancement to its production capacity of biopharmaceutical manufacturing services at AGC Biologics (Headquarters: US), a CDMO(*1) subsidiary of the company.

WINNIPEG, Manitoba, December 18, 2018 /PRNewswire/ --

SINGAPORE and HAMBURG, Germany, Dec. 18, 2018 /PRNewswire/ -- Indivumed GmbH today announced the launch of the "Cancer Library Initiative", an operation to further accelerate precision diagnostics and personalised treatment for cancer patients, in collaboration with A*STAR's Institute... Read more ››

DUBLIN, Dec. 17, 2018 /PRNewswire/ -- A little over a year after raising over EUR 28 million in a private placement, Q3 Medical Devices Limited ("Q3 Medical" or the "Company") based in Dublin, Ireland today announced a new initiative to raise EUR 50 million in a Pre-IPO round that will prepare... Read more ››

ABBOTT PARK, Ill., Dec. 17, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2018 financial results on Wednesday, Jan. 23, 2019, before the market opens.

ABBOTT PARK, Ill., Dec. 14, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 32 cents per share, marking a 14 percent increase.

KALISPELL, Mont., Dec. 13, 2018 /PRNewswire/ -- ClassOne Technology, global supplier of wet processing equipment for <=200mm semiconductor manufacturing, announced the sale of three more tools to the Ferdinand-Braun-Institut, Leibniz-Institut für Höchstfrequenztechnik (FBH) in Berlin, Germany.... Read more ››

SHANGHAI, Dec. 12, 2018 /PRNewswire/ -- Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson's disease has been submitted to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for clinical... Read more ››

ERLANGEN, Germany and HAIFA, Israel, December 11, 2018 /PRNewswire/ --

ABBOTT PARK, Ill., Dec. 11, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 37(th) Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019. Brian Yoor, executive vice president of finance and Chief Financial Officer, will present at the conference at 11 a.m. Central time.... Read more ››

TUCSON, Ariz., Dec. 11, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it entered into a collaboration with Merck (known as MSD outside the United States and Canada) to develop a companion diagnostic test to identify patients eligible for anti-PD-1 therapy based... Read more ››

FLORENCE, Italy, December 11, 2018 /PRNewswire/ --